RevistaLab
he life science ecosystem in Houston is one of the strongest in the country, and this thriving environment is now the 11th largest life science real estate market we track. With slightly under 5 million square feet of space, Houston is a scale below the three primary hubs (Boston/San Fran/San Diego) but is now . . .
U.S. life science manufacturing has had strong tailwinds for more than five years, starting with pandemic-related supply chain disruptions and continuing with the recent policy changes that encourage onshoring. The …
Domestic life science manufacturing is now a focal point, and we are seeing evidence in employment data and our construction data. Data from the Bureau of Labor Statistics shows Pharmaceutical & Medicine Manufacturing Employment on the rise in 2025, after . . .
While several U.S. life science markets have begun to stabilize or show early signs of recovery, San Francisco/San Jose remains in a period of adjustment as new supply continues to …
After several tough years marked by oversupply and slower demand, life science real estate has been searching for a bottom. Most major markets — from Boston to San Francisco and …
To understand each market, we have categorized life science buildings into four age groups. The markets with the most old buildings (built more than 40 years ago) are Chicago, New York and Philadelphia. This is . . .
Life Science real estate has been on a clip of fast expansion, fueled by the increased investor attention and heightened space demand the sector experienced in the wake of the …
What does ownership look like in smaller life science markets? In the chart below we have simplified ownership into either investor or user-owned. The top three markets are dominated by . . .
At the end of 2024, construction starts for life science projects had slowed to the lowest point since the onset of the pandemic, with less than 1 million square feet …
he Worcester Life Science market lies in Central Massachusetts (MA) and serves as a natural growth point for life science companies looking to grow from the Boston/Cambridge CBSA.
The US Life Science or Biotech real estate sector has seen tremendous growth during the past 3 years. Overall, since 2Q22, the US Life Science sector has grown by 17% to 401 million square feet (MSF) in 2Q25.
With many state-of-the-art, brand-new research facilities sitting empty across major research clusters in the U.S., established pharmaceutical and biotechnology firms have an opportunity to secure ideal spaces in prime locations. …
Over the past year a little over 10 million square feet of life science projects have broken ground. While that’s only a fourth of the peak in 2022, it still seems high considering the current gap between supply and demand. To understand . . .
20% of the life science space Revista tracks is pure manufacturing. Despite the oversupply of lab properties, the manufacturing sub section does not suffer the same issues. Manufacturing space is primarily driven by . . .
Last year Life Science inventory in the top 3 clusters, Boston, San Francisco & San Diego, grew by over 10%. With this incredible growth, combined with softer space demand, many …
After a record year of Life Science construction in 2024, early 2025 brings a much needed stall in new project deliveries. In 2024, 22.8 million square feet of Life Science …
Despite declining occupancy in 2024, it was a largely positive year on the demand side. 70% of the top 20 markets had positive absorption in 2024. Boston gained about 3.7 million in occupied space throughout . . .
With a significant amount of new inventory entering the market and weaker demand for space due to the volatile funding environment, the top three life science real estate markets—Boston, San …